Crystal structure of the catalytic domain of the human cell cycle control phosphatase, Cdc25A

被引:261
作者
Fauman, EB [1 ]
Cogswell, JP
Lovejoy, B
Rocque, WJ
Holmes, W
Montana, VG
Piwnica-Worms, H
Rink, MJ
Saper, MA
机构
[1] Univ Michigan, Div Biophys Res, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA
[3] Glaxo Wellcome Inc, Dept Funct Genet, Res Triangle Pk, NC 27709 USA
[4] Glaxo Wellcome Inc, Dept Struct Chem, Res Triangle Pk, NC 27709 USA
[5] Glaxo Wellcome Inc, Dept Mol Sci, Res Triangle Pk, NC 27709 USA
[6] Washington Univ, Sch Med, Dept Cell Biol & Physiol, Howard Hughes Med Inst, St Louis, MO 63110 USA
关键词
D O I
10.1016/S0092-8674(00)81190-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cdc25 phosphatases activate the cell division kinases throughout the cell cycle. The 2.3 Angstrom structure of the human Cdc25A catalytic domain reveals a small alpha/beta domain with a fold unlike previously described phosphatase structures but identical to rhodanese, a sulfur-transfer protein. Only the active-site loop, containing the Cys-(X)(5)-Arg motif, shows similarity to the tyrosine phosphatases. In some crystals, the catalytic Cys-430 forms a disulfide bond with the invariant Cys-384, suggesting that Cdc25 may be self-inhibited during oxidative stress. Asp-383, previously proposed to be the general acid, instead serves a structural role, forming a conserved buried salt-bridge. We propose that Glu-431 may act as a general acid. Structure-based alignments suggest that the noncatalytic domain of the MAP kinase phosphatases will share this topology, as will ACR2, a eukaryotic arsenical resistance protein.
引用
收藏
页码:617 / 625
页数:9
相关论文
共 52 条
  • [41] Structure and function of the low M-r phosphotyrosine protein phosphatases
    Ramponi, G
    Stefani, M
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 1997, 1341 (02): : 137 - 156
  • [42] COMBINING EVOLUTIONARY INFORMATION AND NEURAL NETWORKS TO PREDICT PROTEIN SECONDARY STRUCTURE
    ROST, B
    SANDER, C
    [J]. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 1994, 19 (01) : 55 - 72
  • [43] Structural basis of cyclin-dependent kinase activation by phosphorylation
    Russo, AA
    Jeffrey, PD
    Pavletich, NP
    [J]. NATURE STRUCTURAL BIOLOGY, 1996, 3 (08): : 696 - 700
  • [44] DEPHOSPHORYLATION AND ACTIVATION OF A P34CDC2 CYCLIN-B COMPLEX INVITRO BY HUMAN CDC25 PROTEIN
    STRAUSFELD, U
    LABBE, JC
    FESQUET, D
    CAVADORE, JC
    PICARD, A
    SADHU, K
    RUSSELL, P
    DOREE, M
    [J]. NATURE, 1991, 351 (6323) : 242 - 245
  • [45] STUCKEY JA, 1994, NATURE, V370, P571, DOI 10.1038/370571a0
  • [46] THE CRYSTAL-STRUCTURE OF A LOW-MOLECULAR-WEIGHT PHOSPHOTYROSINE PROTEIN PHOSPHATASE
    SU, XD
    TADDEI, N
    STEFANI, M
    RAMPONI, G
    NORDLUND, P
    [J]. NATURE, 1994, 370 (6490) : 575 - 578
  • [47] The Saccharomyces cerevisiae ACR3 gene encodes a putative membrane protein involved in arsenite transport
    Wysocki, R
    Bobrowicz, P
    Ulaszewski, S
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (48) : 30061 - 30066
  • [48] Xu X, 1996, J BIOL CHEM, V271, P5118
  • [49] Control of cell cycle progression in human natural killer cells through redox regulation of expression and phosphorylation of retinoblastoma gene product protein
    Yamauchi, A
    Bloom, ET
    [J]. BLOOD, 1997, 89 (11) : 4092 - 4099
  • [50] Crystal structure of the dual specificity protein phosphatase VHR
    Yuvaniyama, J
    Denu, JM
    Dixon, JE
    Saper, MA
    [J]. SCIENCE, 1996, 272 (5266) : 1328 - 1331